{"database": "lobbying", "table": "lobbying_activities", "rows": [[2303077, "958e6ab2-2fcc-4534-abcf-9275d3364fbc", "Q2", "THE D MAJOR GROUP", 401103162, "ALLERGAN INC (FORMERLY ACTAVIS INC )", 2019, "second_quarter", "CPT", "Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2019-07-14T22:10:17.490000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2303077"], "units": {}, "query_ms": 0.6075850105844438, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}